The Future Is Biochemical

The field of aesthetics has been defined by its ability to innovate for decades. From the use of botulinum toxin to smoothen wrinkles to the rise of hyaluronic acid fillers, each leap forward has reshaped the way we define and deliver beauty and rejuvenation. Now, we are on the cusp of another transformative moment—one that shifts our focus from structural enhancement to biochemical rejuvenation. This frontier is being shaped by a category I call “biochemical cues”: modalities like exosomes, peptides, growth factors, PDRN (polydeoxyribonucleotide), and other regenerative approaches, which tap into the body’s own healing and repair mechanisms to deliver profound results.

Aesthetic medicine has traditionally revolved around structural corrections—lifting here, filling there, or resurfacing skin. But we now understand that aging is more than a matter of volume loss or wrinkles: It’s also about chronic inflammation, oxidative stress, and the breakdown of cellular communication networks. That’s where these “biochemical cues” I mentioned previously have created a paradigm shift. By leveraging regenerative cues inside the body, we can correct aging at its source by restoring the processes that sustain youth and vitality.

Exosomes—tiny vesicles derived from stem cells—are messengers that can prompt target cells to repair and regenerate, potentially boosting collagen, reducing inflammation, and accelerating wound healing. Peptides, short sequences of amino acids, can be tailored to stimulate everything from collagen synthesis to metabolic optimization. Then there are PDRN and polynucleotides, which come from salmon DNA and are gaining attention for their ability to support tissue regeneration and wound healing. Growth factors, which are proteins that regulate cell growth and repair, have been used for years as a powerful tool in skin rejuvenation. Together, these therapies represent a shift in our understanding of how to keep skin looking healthy, vibrant, and youthful, by recognizing aging as a pathological process influenced by inflammation, oxidative stress, and epigenetic changes.

While the promise of these technologies is significant, so are the challenges. Regulatory frameworks have yet to catch up with the pace of innovation, leaving providers to navigate a murky landscape that is tainted with misinformation from TikTok, Instagram, and other non-trustworthy sources. What is legal in one jurisdiction may be off-limits in another, and the lack of standardization raises questions about safety, efficacy, and ethical practice. These same questions can be raised about the manufacturing processes of some of the companies that make these products, as well as the lack of data to support many claims that are being made.

Meanwhile, the psychological aspects of wellness remind us that beauty and well-being are deeply intertwined. Patients don’t just want to look younger; they want to feel more confident, and more in control of their overall health. By addressing the root causes of aging at the biochemical level, we may also address deeper aspects of wellness.

Now that this paradigm shift has arrived, our industry must grapple with questions of accessibility, evidence, and education. How do we make these treatments broadly available without compromising on safety? How do we build a robust body of evidence for therapies that are still in their infancy (most of which are not FDA-approved)? And how do we educate providers and patients about the potential—and limitations—of this new paradigm?

I believe the answers will define the next chapter of aesthetics. What’s clear to me is that the future is biochemical. Providers who embrace this shift, incorporating regenerative therapies alongside traditional techniques, will not only stay ahead of the curve but also redefine what it means to practice aesthetic medicine.